$GRHI
GOLD ROCK HOLDINGS, INC.

2023 Q2 Form 10-Q Financial Statement

#000109181823000069 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.30K $196.4K
YoY Change 0.48% 282.4%
Operating Profit -$10.30K -$196.4K
YoY Change 0.48% 282.4%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $3.000K $3.000K
YoY Change 0.0% 0.0%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$10.30K -$196.4K
YoY Change 0.48% 282.4%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 231.1M shares 87.48M shares 87.48M shares
Diluted Shares Outstanding 231.1M shares 93.86M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.188K $1.236K $1.284K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $5.725K
Receivables
Other Receivables
Total Short-Term Assets $1.188K $6.961K $1.284K
YoY Change -30.12% -24.47%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.188K $6.961K $1.284K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $1.188K $6.961K $1.284K
YoY Change -30.12% -24.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.975K $2.210K $403.2K
YoY Change -89.21% 3820.03%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.975K $2.210K $403.2K
Total Long-Term Liabilities
Total Liabilities $4.975K $2.210K $403.2K
YoY Change -89.21% 3820.03%
SHAREHOLDERS EQUITY
Retained Earnings -$840.4K -$830.1K -$633.7K
YoY Change 221.81% 217.59%
Common Stock $231.1K $231.1K $87.48K
YoY Change 164.11% 0.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.787K $4.751K -$401.9K
YoY Change
Total Liabilities & Shareholders Equity $1.188K $6.961K $1.284K
YoY Change -30.12% -24.47%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$10.30K -$196.4K
YoY Change 0.48% 282.4%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$48.00
YoY Change -99.73%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -$48.00
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -$48.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$48.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000894501
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2023Q1 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2022Q1 grhi Common Shares Issued For Consulting
CommonSharesIssuedForConsulting
usd
CY2022Q1 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2023Q1 grhi Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
usd
CY2022Q1 us-gaap Interest Paid
InterestPaid
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-56304
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
GOLD ROCK HOLDINGS, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0434297
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
2020 General Booth Blvd.
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Virginia Beach
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
23454
CY2023Q1 dei City Area Code
CityAreaCode
(757)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
306-6090
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
231053636 shares
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1000 usd
CY2023Q1 grhi Common Shares Issued For Consulting
CommonSharesIssuedForConsulting
172000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1236 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1284 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5725 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
6961 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1284 usd
CY2023Q1 us-gaap Assets
Assets
6961 usd
CY2022Q4 us-gaap Assets
Assets
1284 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2210 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
372175 usd
CY2022Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
31000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2210 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
403175 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2210 usd
CY2022Q4 us-gaap Liabilities
Liabilities
403175 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
231053636 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
231053636 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87482208 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87482208 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
231053 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
87482 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
603782 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
144353 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-830084 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-633726 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4751 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-401891 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6961 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1284 usd
CY2023Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
170000 usd
CY2022Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
30000 usd
CY2023Q1 grhi Consulting Fees Expenses
ConsultingFeesExpenses
3000 usd
CY2022Q1 grhi Consulting Fees Expenses
ConsultingFeesExpenses
3000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23358 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18349 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
196358 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
51349 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-196358 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-51349 usd
CY2023Q1 grhi Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
93863160 shares
CY2022Q1 grhi Weighted Average Number Of Common Shares Basic And Diluted
WeightedAverageNumberOfCommonSharesBasicAndDiluted
87397764 shares
CY2023Q1 grhi Net Loss For Period Per Common Shares Basic And Diluted
NetLossForPeriodPerCommonSharesBasicAndDiluted
-0.00
CY2023Q1 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
29000 usd
CY2022Q1 grhi Net Loss For Period Per Common Shares Basic And Diluted
NetLossForPeriodPerCommonSharesBasicAndDiluted
-0.00
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-196358 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-51349 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
5725 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1035 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2825 usd
CY2022Q1 grhi Increase Decrease In Accrued Board Of Directors Compensation
IncreaseDecreaseInAccruedBoardOfDirectorsCompensation
-30000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17524 usd
CY2022Q1 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
17524 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17524 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-48 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1284 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1700 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1236 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1700 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-8585 usd
CY2022Q1 grhi Capital Contributions Director
CapitalContributionsDirector
17524 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-51349 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-41410 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-401891 usd
CY2023Q1 grhi Common Stock Issued For Accounts Payable And Accrued Expenses
CommonStockIssuedForAccountsPayableAndAccruedExpenses
402000 usd
CY2023Q1 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expense
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpense
29000 usd
CY2023Q1 grhi Common Stock Issued For Board Of Director Consulting Services
CommonStockIssuedForBoardOfDirectorConsultingServices
172000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-196358 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4751 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_848_eus-gaap--UseOfEstimates_zF2c0NZlhHWc" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zbsR4aThXyk9">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-830084 usd
CY2023Q1 grhi Working Capital
WorkingCapital
4751 usd
CY2023Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
23275 usd
CY2022Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
17524 usd
CY2023Q1 grhi Common Stock Issued To Prepay Director For Payment Of Operating Expenses
CommonStockIssuedToPrepayDirectorForPaymentOfOperatingExpenses
29000 usd
CY2023Q1 grhi Stock Issuance To Reimburse
StockIssuanceToReimburse
0.0042
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
17524 usd
CY2023Q1 grhi Agreement Monthly Charges
AgreementMonthlyCharges
1000 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
3000 usd
CY2022Q1 us-gaap Other Expenses
OtherExpenses
3000 usd
CY2023Q1 grhi Accounts Payable
AccountsPayable
1000 usd
CY2022Q4 grhi Accounts Payable
AccountsPayable
21000 usd
CY2023Q1 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
The Company had a 5 year compensation agreement with its Board Chairman beginning January 1, 2022 and ending on December 31, 2026. Compensation was an annual fee of $30,000, due in the following month of January.
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
30000 usd
CY2022Q4 grhi Accrued Board Of Director Compensation
AccruedBoardOfDirectorCompensation
31000 usd
CY2023Q1 grhi Board Of Director Compensation
BoardOfDirectorCompensation
95000 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
850000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
231053636 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
231053636 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
87482208 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87482208 shares
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
40952381 shares
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
172000 usd
CY2023Q1 grhi Common Stock Issued For Consulting And Director Compensation Shares
CommonStockIssuedForConsultingAndDirectorCompensationShares
6904761 shares
CY2023Q1 grhi Common Stock Issued For Consulting And Director Compensation
CommonStockIssuedForConsultingAndDirectorCompensation
29000 usd
CY2023Q1 grhi Common Stock Issued For Accounts Payable And Accrued Expenses
CommonStockIssuedForAccountsPayableAndAccruedExpenses
402000 usd

Files In Submission

Name View Source Status
0001091818-23-000069-index-headers.html Edgar Link pending
0001091818-23-000069-index.html Edgar Link pending
0001091818-23-000069.txt Edgar Link pending
0001091818-23-000069-xbrl.zip Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
grhi-20230331.xsd Edgar Link pending
grhi20230331.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
grhi-20230331_cal.xml Edgar Link unprocessable
grhi-20230331_def.xml Edgar Link unprocessable
grhi-20230331_lab.xml Edgar Link unprocessable
grhi-20230331_pre.xml Edgar Link unprocessable
grhi20230331_htm.xml Edgar Link completed